miR-210 is a Serological Biomarker for Predicting Recurrence and Prognosis of Colon Carcinoma Patients with Liver Metastases After Radiofrequency Ablation Treatment

PURPOSE: Hepatic metastasis of colon carcinoma seriously affects the prognosis of patients, and miRNA has attracted much attention in predicting hepatic metastasis of colon carcinoma (CC). This research aimed to explore the predictive role of miR-210 in serum for recurrence and prognosis of CC patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yong, Zhou, Yu-Mei, Zhang, Zu-Jian, Li, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524199/
https://www.ncbi.nlm.nih.gov/pubmed/33061602
http://dx.doi.org/10.2147/CMAR.S267731

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524199/
https://www.ncbi.nlm.nih.gov/pubmed/33061602
http://dx.doi.org/10.2147/CMAR.S267731

Ejemplares similares